Kimberly Amanda Scotto

Kimberly Scotto practices at Bislr Medical Groups Of Mount Sinai in New York, New York.

Kimberly Scotto's NPI, 1740523216, was assigned on April 2, 2013. Kimberly Scotto holds New York license 286251.

Kimberly Scotto's primary practice is Bislr Medical Groups of Mount Sinai, at 200 W 57th St, New York, NY 10019. The practice phone is (212) 663-6604.

Kimberly Scotto's primary practice is Bislr Medical Groups Of Mount Sinai in New York, New York. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Kimberly Scotto to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimberly Scotto practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Kimberly Scotto's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kimberly Scotto is licensed in New York.

CMS data shows 892 Medicare services from Kimberly Scotto across 11 procedure codes in 2024, for 221 Medicare patients. Medicare paid $53,524 for them. Every service was in an office.

CMS counts 221 Medicare patients who saw Kimberly Scotto in 2024. The largest group is 65 to 74, with 124 patients. 70% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kimberly Scotto's median patient age at 52, with 78% women.

In 2024, Kimberly Scotto wrote 2,569 Medicare Part D claims for 357 patients. 90% of them were for generic drugs. CMS names the drug for 2,124 of them, across 52 drugs with 11 or more claims each, at $120,286 in total drug cost. In 2023, CMS named 1,656 claims across 41 drugs.

Kimberly Scotto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kimberly Scotto as offering telehealth.

CMS Open Payments shows 1 general payment to Kimberly Scotto from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $118.